2020 ESO/ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版

2020-09-23 欧洲肿瘤学校 Ann Oncol . 2020 Sep 23;

2020年9月,晚期乳腺癌(ABC 5)国际共识指南第5版发布。指南主要针对晚期乳腺癌的管理提供关键指导建议,对于所有乳腺癌亚型患者、LABC、随访、姑息和支持性治疗提供了更新的管理建议,以及最新的诊

中文标题:

2020 ESO/ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版

英文标题:

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

发布机构:

欧洲肿瘤学校

发布日期:

2020-09-23

简要介绍:

2020年9月,晚期乳腺癌(ABC 5)国际共识指南第5版发布。指南主要针对晚期乳腺癌的管理提供关键指导建议,对于所有乳腺癌亚型患者、LABC、随访、姑息和支持性治疗提供了更新的管理建议,以及最新的诊治流程。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ESO_ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=7efdf1c00198e93a, title=2020 ESO/ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版, enTitle=5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5), guiderFrom=Ann Oncol . 2020 Sep 23;, authorId=0, author=, summary=2020年9月,晚期乳腺癌(ABC 5)国际共识指南第5版发布。指南主要针对晚期乳腺癌的管理提供关键指导建议,对于所有乳腺癌亚型患者、LABC、随访、姑息和支持性治疗提供了更新的管理建议,以及最新的诊, cover=https://img.medsci.cn/2020106/1601997936200_2020535.jpg, journalId=0, articlesId=null, associationId=692, associationName=欧洲肿瘤学校, associationIntro=欧洲肿瘤学校(ESO)由Umberto Veronesi和Laudomia Del Drago在1982年建立,目的在于减少由于晚期诊断和不充分治疗造成的癌症死亡。, copyright=0, guiderPublishedTime=Wed Sep 23 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年9月,晚期乳腺癌(ABC 5)国际共识指南第5版发布。指南主要针对晚期乳腺癌的管理提供关键指导建议,对于所有乳腺癌亚型患者、LABC、随访、姑息和支持性治疗提供了更新的管理建议,以及最新的诊治流程。</p> </div> </div> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12433, appHits=291, showAppHits=0, pcHits=2017, showPcHits=12142, likes=3, shares=13, comments=6, approvalStatus=1, publishedTime=Wed Oct 07 00:06:44 CST 2020, publishedTimeString=2020-09-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 06 23:25:42 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:43:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESO_ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版.pdf)])
2020 ESO_ESMO国际共识指南:晚期乳腺癌(ABC 5)-第5版.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200383, encodeId=f477120038335, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056f6241882, createdName=194176_1796, createdTime=Mon Mar 07 23:01:09 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925203, encodeId=1a7192520358, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04505460782, createdName=ms9000001449179757, createdTime=Thu Feb 18 09:06:26 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901718, encodeId=a3fd901e1834, content=good materials, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baf05437981, createdName=ms9000000356596930, createdTime=Tue Nov 24 12:02:54 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892846, encodeId=7cf789284668, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:43 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892845, encodeId=86a7892845d1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:39 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2022-03-07 194176_1796

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200383, encodeId=f477120038335, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056f6241882, createdName=194176_1796, createdTime=Mon Mar 07 23:01:09 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925203, encodeId=1a7192520358, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04505460782, createdName=ms9000001449179757, createdTime=Thu Feb 18 09:06:26 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901718, encodeId=a3fd901e1834, content=good materials, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baf05437981, createdName=ms9000000356596930, createdTime=Tue Nov 24 12:02:54 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892846, encodeId=7cf789284668, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:43 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892845, encodeId=86a7892845d1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:39 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2021-02-18 ms9000001449179757

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200383, encodeId=f477120038335, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056f6241882, createdName=194176_1796, createdTime=Mon Mar 07 23:01:09 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925203, encodeId=1a7192520358, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04505460782, createdName=ms9000001449179757, createdTime=Thu Feb 18 09:06:26 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901718, encodeId=a3fd901e1834, content=good materials, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baf05437981, createdName=ms9000000356596930, createdTime=Tue Nov 24 12:02:54 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892846, encodeId=7cf789284668, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:43 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892845, encodeId=86a7892845d1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:39 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2020-11-24 ms9000000356596930

    good materials

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200383, encodeId=f477120038335, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056f6241882, createdName=194176_1796, createdTime=Mon Mar 07 23:01:09 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925203, encodeId=1a7192520358, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04505460782, createdName=ms9000001449179757, createdTime=Thu Feb 18 09:06:26 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901718, encodeId=a3fd901e1834, content=good materials, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baf05437981, createdName=ms9000000356596930, createdTime=Tue Nov 24 12:02:54 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892846, encodeId=7cf789284668, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:43 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892845, encodeId=86a7892845d1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:39 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2020-10-18 answer.col

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200383, encodeId=f477120038335, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=056f6241882, createdName=194176_1796, createdTime=Mon Mar 07 23:01:09 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925203, encodeId=1a7192520358, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04505460782, createdName=ms9000001449179757, createdTime=Thu Feb 18 09:06:26 CST 2021, time=2021-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901718, encodeId=a3fd901e1834, content=good materials, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=baf05437981, createdName=ms9000000356596930, createdTime=Tue Nov 24 12:02:54 CST 2020, time=2020-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892846, encodeId=7cf789284668, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:43 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892845, encodeId=86a7892845d1, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKT6cbtvT3o7icibpicpHiamGPlBJiaToQoNdqibGHpfiaibg9Mx79wgicJ7lM43SzmXibeZI8oIEh2vZvnhUtw/132, createdBy=744b2171805, createdName=answer.col, createdTime=Sun Oct 18 14:24:39 CST 2020, time=2020-10-18, status=1, ipAttribution=)]
    2020-10-18 answer.col

    好共识

    0

拓展阅读

乳腺癌HER2检测指南(2009版)

中国肿瘤科相关专家小组(统称) · 2009-12-01

2010 乳腺癌骨转移和骨相关疾病临床诊疗专家共识(2010版)

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2010-01-01

2010 SBI/ACR推荐建议:乳腺癌影像学筛查

乳腺影像学会(SBI,Society of Breast Imaging) · 2010-01-20

2010 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2010-02-01

2010 ASCO-CAP指南:乳腺癌患者雌激素和雄激素受体的免疫组化检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-04-19

2010 ASCO指南:激素受体阳性乳腺癌妇女的辅助内分泌治疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-07-12